BioNJ, The Gateway to Health, is a powerful network of 400 Member Investors representing research-based life sciences companies and stakeholders dedicated to propelling a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount. Because Patients Can’t Wait, BioNJ is committed to the growth and prosperity of New Jersey’s life sciences ecosystem to help accelerate the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society. As the industry’s voice in New Jersey, we fulfill our Mission to help our Members help Patients by driving capital formation and fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources. For more information about BioNJ, please visit https://www.BioNJ.org
Bionow is a specialist business development and services company focused on the biomedical industry in the North of England. We provide innovative products and services that deliver tangible value, enabling our members to be the most productive and competitive in the world. Our offering spans procurement, insurance, recruitment training and consultancy plus specialist events (both local and national) and access into a large, vibrant network of businesses, universities and NHS organisations. Commenced in July 2011 and already bringing benefit to over 160 subscribing members the Bionow membership scheme offers significant bottom line savings.
BioPartner UK is the independent, accredited trade organisation that promotes international partnering for trade, investment and collaborations with UK life science enterprises. BioPartner’s UK Delegations promote the UK presence at international conferences. We work with conference organisers, in-country agencies and overseas networks to provide the best business opportunities for our members and UK companies travelling with outward delegations. BioPartner also provides access to government grants and entry fee discounts for all UK-based organisations.
BioPharmaLogic Ltd expedits all aspects of nonclinical drug development from pharmacology to post-licensing regulatory activity and life cycle management.
As a specialist marketing agency working in life science, our team is fluent in the languages of science and business.
We combine PhD level knowledge with decades of marketing experience to develop integrated programmes that deliver results for life science companies.
We aim to provide life science companies with marketing support that delivers additional expertise where needed and relieves the stress of internal marketing teams through proactive programs that produce results.
With an inherent and in-depth knowledge of both science and business, we communicate effectively with every stakeholder. We turn technical knowledge and insight into creative and inspiring messages that resonate with customers and drive action.
Telling your story comes naturally to us — it’s in our genes. Contact us now, and let’s set about telling yours.
We combine PhD level knowledge with decades of marketing experience to develop integrated programmes that deliver results for life science companies.
We aim to provide life science companies with marketing support that delivers additional expertise where needed and relieves the stress of internal marketing teams through proactive programs that produce results.
With an inherent and in-depth knowledge of both science and business, we communicate effectively with every stakeholder. We turn technical knowledge and insight into creative and inspiring messages that resonate with customers and drive action.
Telling your story comes naturally to us — it’s in our genes. Contact us now, and let’s set about telling yours.
Contract manufacturer of biologics for immunodiagnostic, bio-pharmaceutical and environmental biotechnology applications. Contract RD; creation, development and optimisation of cell lines; process development and validation; production and purification of proteins (milligram to multi-gram quantities)to enable characterisation, pre-clinical testing, and scale-up for clinical trials.. Specialist in hybridoma technology and production/purification of monoclonal antibodies and recombinant proteins from mammalian cell lines. . . Development of bioassays for environmental monitoring. Microbial and monoclonal antibody-based bioassays for identifying pathogens and determining toxicity of wastewater and groundwater.. . Technologies: Hollowfibre bioreactors; spinner/roller culture; stirred vessel bioreactors; Affinity, ion-exchange and size exclusion chromatography.
BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers. Visit the BIO Member Directory to browse BIO members and Web site links as well as BIO state and international affiliates.. . Member services include: . * Federal and state advocacy on issues affecting the industry . * A dozen or more investor and partnering meetings throughout the year, with discounts for members . * Communications services that disseminate information about the benefits of biotechnology . * BIO Business Solutions discounts for a variety of goods and services . . Specific issues may have changed over the years, but our core mission of fostering biotechnology innovation through advocacy, business development and communications remains the same. . . BIO produces the annual BIO International Convention, the world's largest gathering of the biotechnology industry. The BIO International Convention attracts more than 20,000 attendees from around the world including more than 500 members of the international press. Convention attendees hear from global biotechnology leaders, learn about the latest biotech innovations and network with their peers from established and emerging biotech companies, research institutions, service providers and biotech hubs.. . BIO also produces a series of industry-leading investor and partnering meetings held around the world.
No data available
BMG LABTECH's modular and fully upgradeable microplate reading systems include a range of features such as 65°C incubation, fully integrated O2/CO2 atmospheric control and ultrafast UV/Vis spectrometer based absorbance. BMG’s instruments offer fluorescence,(including FP), absorbance (including the low UV range),and both glow-and flash luminescence. Uniquely the nephelometer measures light scatter perfect for solubility studies. These instruments provide the highest sensitivity, flexibility and reliability and are designed to be easily integrated into automated systems for HTS assays. All BMG’s readers are supported by a team of engineers, scientists, and technicians dedicated to bringing you high-quality products of exceptional value and performance.
BOC Cryospeed is the UK and Ireland's most reliable and flexible supplier of mini-bulk liquid gases to support science. Cryospeed delivers liquid nitrogen, argon, oxygen and carbon dioxide. BOC is the UK’s largest supplier of speciality gases and equipment and has an unrivalled supply of gases and products to suit any application, plus many more that can be customised to match your requirements: Ecocyl, a unique portable package designed to meet requirements of low gas usage; a database of over 25000 individual gas product recipes. We can also customise products to your specification; gas control equipment.